Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
SKYTROFA® (Lonapegsomatropin-tcgd), The First Therapy Discovered for Pediatric Growth Hormone Deficiency
Acendis Pharma has made a significant discovery in the form of SKYTROFA (lonapegsomatropin-tcgd), a groundbreaking treatment for pediatric growth hormone deficiency....
New Simoa® phospho-Tau 181 (pTau-181) Blood Test Discovered for Alzheimer’s Disease
Quanterix Corporation discovers new Blood-Based pTau-181 Assay for Alzheimer’s Disease. The Simoa® phospho-Tau 181 (pTau-181) blood test will be used for diagnostic evaluation of Alzheimer’s Disease (AD). With the use of HD-X immunoassay system, the pTau-181 concentration in human serum...
Genentech Developed Breakthrough Therapy Gantenerumab for Alzheimer’s Disease
Genentech has developed a groundbreaking therapy for the treatment of early Alzheimer's disease (AD). This therapy, called Gantenerumab, is the first medicine designed to be administered at home for the treatment of Alzheimer's disease....
Novel Novilase® Interstitial Laser System Developed for Breast Cancer
Novian Health Inc. developed Novilase® Interstitial Laser System for the treatment of malignant breast tumors for adult women who undergo breast conserving procedure. The laser therapy helps patients by keeping away from trauma and works as an alternative for breast cancer surgery....
Jardiance® Novel Therapy Developed for the Treatment of Patients with Heart Failure
Eli Lilly and Company in combination with Boehringer Ingelheim has developed Jardiance®, a novel therapy to treat patients with heart failure with preserved ejection fraction (HFpEF). Jardiance is used to lower the blood sugar levels along with diet and exercise in adults with type 2 diabetes, lessens the risk of cardiovascular...
Amdizalisib (HMPL-689) Discovered for the Treatment of Relapsed or Refractory Follicular Lymphoma
Hutchmed Limited discovered novel therapy amdizalisib (HMPL-689), for the treatment of relapsed or refractory follicular lymphoma (“FL”). Amdizalisib is an inhibitor for PI3Kδ (phosphoinositide 3-kinase delta),a lipid kinase which helps in controlling the activation of several important signaling proteins...
Novel Phoenix® Therapy Developed to Treat PTSD
Evren Technologies has developed a groundbreaking therapy called Phoenix® specifically designed for the treatment of Post-traumatic Stress Disorder (PTSD)....
Genentech Developed Breakthrough Therapy Venclexta for Myelodysplastic Syndromes
Genentech developed Venclexta in combination with Azacitidine for the treatment of patients with Myelodysplastic Syndromes. Venclexta in combination with Azacitidine has the ability to treat adult patients who have formerly untreated with intermediate, high- and very high-risk myelodysplastic...
Novel Therapy, Toripalimab, Discovered for the Treatment of Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma in combination with Coherus discovered Toripalimab, novel therapy for the treatment of recurrent or metastatic nasopharyngeal carcinoma. Toripalimab, is an anti-PD-1 monoclonal antibodyhaving the ability to block PD-1interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor internalization (endocytosis function)....
Adagrasib Discovered for the Treatment of Advanced Non-Small Cell Lung Cancer
Mirati Therapeutics discovered novel therapy, Adagrasib for the treatment of patients with non-small cell lung cancer (NSCLC) harbouring the KRASG12C Mutation. Adagrasib is an investigational, selective and oral small-molecule inhibitor of KRASG12C which is developed to support target inhibition, as KRASG12C protein regenerates...
